Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Conditions
Interventions
adapalene/benzoyl peroxide
Topical Gel Vehicle
Locations
25
United States
UAB Dermatology Clinical Research
Birmingham, Alabama, United States
Children's Hospital and Health Center Division of Pediatric and Adolescent Dermatology
San Diego, California, United States
Redwood Family Dermatology
Santa Rosa, California, United States
FXM Research Miramar
Miramar, Florida, United States
Adult & Pediatric Dermatology
Overland Park, Kansas, United States
Dermatology Specialists Research
Louisville, Kentucky, United States
Start Date
June 1, 2010
Primary Completion Date
August 1, 2011
Completion Date
August 1, 2011
Last Updated
February 18, 2021
NCT05639933
NCT07058883
NCT07406893
NCT07368764
NCT07205107
NCT07151599
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions